Buy Ranbaxy Laboratories at current levels: Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Ranbaxy Laboratories is a deadly stock to trade in. At current levels, it is a buy, not a sell; it is one of those exceptions. But keep a stoploss because markets can do anything."

At 11:00 hrs Ranbaxy Laboratories was quoting at Rs 432.65, up Rs 6.50, or 1.53 percent. It has touched an intraday high of Rs 434.30 and an intraday low of Rs 425. The share touched its 52-week high Rs 525 and 52-week low Rs 253.95 on 03 January, 2013 and 02 August, 2013, respectively. Currently, it is trading 17.59 percent below its 52-week high and 70.37 percent above its 52-week low. Market capitalisation stands at Rs 18,307.23 crore.